PlainRecalls
FDA Drug Low Class III Terminated

Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11

Reported: September 19, 2018 Initiated: September 6, 2018 #D-1185-2018

Product Description

Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11

Reason for Recall

Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.

Details

Recalling Firm
Par Pharmaceutical, Inc.
Units Affected
16,207 (bottles of 30 tablets)
Distribution
United States nationwide
Location
Chestnut Ridge, NY

Frequently Asked Questions

What product was recalled?
Pramipexole dihydrochloride extended release tablets, 0.75 mg, packaged in 30-count bottles, Rx only, Manufactured by: Par Pharmaceutical, Chestnut Ridge, NY 10977, NDC 10370-252-11. Recalled by Par Pharmaceutical, Inc.. Units affected: 16,207 (bottles of 30 tablets).
Why was this product recalled?
Failed impurities/degradation specifications: Finished product contain a known product impurity about current specification levels.
Which agency issued this recall?
This recall was issued by the FDA Drug on September 19, 2018. Severity: Low. Recall number: D-1185-2018.